Literature DB >> 26657269

Physicochemical and mechanical properties of paracetamol cocrystal with 5-nitroisophthalic acid.

Stevanus Hiendrawan1, Bambang Veriansyah2, Edward Widjojokusumo2, Sundani Nurono Soewandhi3, Saleh Wikarsa3, Raymond R Tjandrawinata4.   

Abstract

We report novel pharmaceutical cocrystal of a popular antipyretic drug paracetamol (PCA) with coformer 5-nitroisophhthalic acid (5NIP) to improve its tabletability. The cocrystal (PCA-5NIP at molar ratio of 1:1) was synthesized by solvent evaporation technique using methanol as solvent. The physicochemical properties of cocrystal were characterized by powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), thermogravimetry analysis (TGA), fourier transform infrared spectroscopy (FTIR), hot stage polarized microscopy (HSPM) and scanning electron microscopy (SEM). Stability of the cocrystal was assessed by storing them at 40°C/75% RH for one month. Compared to PCA, the cocrystal displayed superior tableting performance. PCA-5NIP cocrystal showed a similar dissolution profile as compared to PCA and exhibited good stability. This study showed the utility of PCA-5NIP cocrystal for improving mechanical properties of PCA.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-Nitroisophhthalic acid; 5-Nitroisophthalic acid (PubChem CID: 12069); Acetonitrille (PubChem CID: 6342); Cocrystal; Dissolution rate; Mechanical properties; Methanol (PubChem CID: 887); Paracetamol; Paracetamol (PubChem CID: 1983); Potassium dihydrogen phosphate (PubChem CID: 516951); Sodium hydroxide (PubChem CID: 14798)

Mesh:

Substances:

Year:  2015        PMID: 26657269     DOI: 10.1016/j.ijpharm.2015.12.001

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

Review 1.  Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs.

Authors:  Anna Karagianni; Maria Malamatari; Kyriakos Kachrimanis
Journal:  Pharmaceutics       Date:  2018-01-25       Impact factor: 6.321

2.  The Role of Cocrystallization-Mediated Altered Crystallographic Properties on the Tabletability of Rivaroxaban and Malonic Acid.

Authors:  Dnyaneshwar P Kale; Vibha Puri; Amit Kumar; Navin Kumar; Arvind K Bansal
Journal:  Pharmaceutics       Date:  2020-06-12       Impact factor: 6.321

3.  DSC, FTIR and Raman Spectroscopy Coupled with Multivariate Analysis in a Study of Co-Crystals of Pharmaceutical Interest.

Authors:  Patrycja Garbacz; Marek Wesolowski
Journal:  Molecules       Date:  2018-08-24       Impact factor: 4.411

4.  Cocrystal of Ibuprofen⁻Nicotinamide: Solid-State Characterization and In Vivo Analgesic Activity Evaluation.

Authors:  Yori Yuliandra; Erizal Zaini; Syofyan Syofyan; Wenny Pratiwi; Lidiya Novita Putri; Yuti Sahra Pratiwi; Helmi Arifin
Journal:  Sci Pharm       Date:  2018-06-04

5.  Characterizations and Assays of α-Glucosidase Inhibition Activity on Gallic Acid Cocrystals: Can the Cocrystals be Defined as a New Chemical Entity During Binding with the α-Glucosidase?

Authors:  Na Xue; Yutao Jia; Congwei Li; Binnan He; Caiqin Yang; Jing Wang
Journal:  Molecules       Date:  2020-03-05       Impact factor: 4.411

6.  Two Novel Palbociclib-Resorcinol and Palbociclib-Orcinol Cocrystals with Enhanced Solubility and Dissolution Rate.

Authors:  Chenxin Duan; Wenwen Liu; Yunwen Tao; Feifei Liang; Yanming Chen; Xinyi Xiao; Guisen Zhang; Yin Chen; Chao Hao
Journal:  Pharmaceutics       Date:  2021-12-23       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.